This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Cancer is an insidious and dangerous disease that affects millions of people around the world, and researchers have been working tirelessly to find new treatments and cures for this devastating illness. In recent years, there have been some remarkable advances in cancer research that offer hope and promise in the fight against cancer. One of the biggest advancements in cancer research has been the use of immunotherapy. Immunotherapy is a type of treatment that uses the body’s own immune system to fight cancer cells. By harnessing the power of the immune system, this treatment is able to target specific cancer cells and destroy them without damaging healthy cells. This has been especially effective in treating certain types of leukemia and lymphoma. Another exciting development in cancer research is the use of gene therapy. This type of therapy uses modified genes to treat cancer. By introducing these modified genes into the body, researchers can target specific cancer cells and either destroy them or change them in such a way that they can no longer cause harm. This method has been especially effective in treating certain types of breast and lung cancer. Finally, researchers have been exploring the use of nanotechnology in cancer treatment. Nanotechnology involves using tiny particles to target and destroy cancer cells. This method is still in its early stages, but it has already shown great promise in treating certain types of cancer. These advances in cancer research offer great hope to those affected by this devastating disease. With continued research, scientists and medical professionals are confident that even more progress can be made, leading to better treatments and eventually a cure for cancer.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States